MIT Develops 3D-Printed Electrospray Array for Low-Cost Microparticle Production
Researchers at MIT have created a 3D-printed electrospray array that can efficiently produce microparticles for drug delivery at a lower cost.
Scientists at the Massachusetts Institute of Technology (MIT) have successfully developed a novel electrospray array fabricated using 3D printing technology. This advancement aims to significantly reduce the cost associated with mass-producing microparticles, which are crucial for various applications, particularly in drug delivery systems.
The new electrospray array is designed to enable high-throughput production of these microparticles. Traditional methods for creating microparticles can be complex and expensive, limiting their widespread adoption. The 3D-printed array offers a more accessible and scalable solution.
This innovative approach utilizes additive manufacturing to create intricate nozzle geometries within the array, allowing for precise control over the electrospray process. By optimizing the design and material properties through 3D printing, the researchers have enhanced the efficiency and uniformity of microparticle generation. This could pave the way for more affordable and readily available microparticle-based therapeutics and other advanced materials.
The development is a significant step towards democratizing the production of specialized microparticles, potentially impacting pharmaceutical manufacturing and research by making advanced drug delivery technologies more economically viable.
This development leverages additive manufacturing to create a cost-effective and scalable solution for microparticle production using electrospray technology. Such advancements are critical for the pharmaceutical industry, enabling more efficient and affordable manufacturing of drug delivery systems. The ability to precisely control particle size and distribution through 3D printing opens doors for personalized medicine and advanced material fabrication.
Edited by the news editor with AI and translated into English from the original report — please refer to the original source.